NAB2 is a novel immune stimulator of MDA-5 that promotes a strong type I interferon response
Published inOncotarget, vol. 9, no. 5, p. 5641-5651
Publication date2017
Abstract
Research groups
Citation (ISO format)
OBERSON, Anne et al. NAB2 is a novel immune stimulator of MDA-5 that promotes a strong type I interferon response. In: Oncotarget, 2017, vol. 9, n° 5, p. 5641–5651. doi: 10.18632/oncotarget.23725
Main files (2)
Article (Accepted version)
Article (Published version)
Identifiers
- PID : unige:114099
- DOI : 10.18632/oncotarget.23725
- PMID : 29464024
Journal ISSN1949-2553